Capital Management Corp Gilead Sciences, Inc. Transaction History

Capital Management Corp

$488 Million
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$64.88 - $73.64 $3.67 Million - $4.17 Million	-56,614 Closed	0 $0
Q3 2021 Oct 25, 2021	SELL	$67.69 - $73.03 $5.28 Million - $5.7 Million	-77,984 Reduced 57.94%	56,614 $3.96 Million
Q2 2021 Jul 30, 2021	SELL	$63.47 - $69.35 $3.41 Million - $3.73 Million	-53,730 Reduced 28.53%	134,598 $9.27 Million
Q1 2021 Apr 26, 2021	BUY	$60.0 - $68.46 $2.2 Million - $2.51 Million	36,680 Added 24.19%	188,328 $12.2 Million
Q4 2020 Feb 04, 2021	BUY	$56.65 - $64.55 $453 - $516	8 Added 0.01%	151,648 $8.84 Million
Q3 2020 Oct 27, 2020	BUY	$62.1 - $78.08 $1.95 Million - $2.45 Million	31,325 Added 26.04%	151,640 $9.58 Million
Q2 2020 Jul 29, 2020	SELL	$72.34 - $84.0 $3.51 Million - $4.08 Million	-48,555 Reduced 28.75%	120,315 $9.26 Million
Q1 2020 May 05, 2020	BUY	$62.63 - $80.22 $2.21 Million - $2.83 Million	35,220 Added 26.35%	168,870 $12.6 Million
Q4 2019 Feb 03, 2020	SELL	$61.62 - $67.78 $239,147 - $263,054	-3,881 Reduced 2.82%	133,650 $8.69 Million
Q3 2019 Oct 30, 2019	BUY	$62.51 - $69.0 $19,128 - $21,114	306 Added 0.22%	137,531 $8.72 Million
Q2 2019 Jul 31, 2019	BUY	$61.87 - $69.38 $650,501 - $729,461	10,514 Added 8.3%	137,225 $9.27 Million
Q1 2019 Apr 25, 2019	BUY	$62.53 - $70.05 $2.44 Million - $2.73 Million	38,983 Added 44.44%	126,711 $8.24 Million
Q4 2018 Jan 29, 2019	SELL	$60.54 - $79.0 $2.64 Million - $3.44 Million	-43,554 Reduced 33.18%	87,728 $5.49 Million
Q3 2018 Oct 31, 2018	BUY	$71.28 - $78.92 $150,044 - $166,126	2,105 Added 1.63%	131,282 $10.1 Million
Q2 2018 Jul 27, 2018	BUY	$64.88 - $75.68 $858,232 - $1 Million	13,228 Added 11.41%	129,177 $9.15 Million
Q1 2018 Apr 25, 2018	SELL	$72.84 - $88.8 $67,231 - $81,962	-923 Reduced 0.79%	115,949 $8.74 Million
Q4 2017 Jan 30, 2018	SELL	$71.15 - $83.52 $710,503 - $834,030	-9,986 Reduced 7.87%	116,872 $8.37 Million
Q3 2017 Nov 01, 2017	BUY	$72.11 - $85.47 $9.15 Million - $10.8 Million	126,858	126,858 $10.3 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.1 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.07 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.71 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.56 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Management Corp , based on Form 13F filings with the SEC.

News

Stay updated on Capital Management Corp with notifications on news.

Account